Abstract
Objectives
This study aimed to evaluate whether the expression of circulating dystromiRs and a group of oxidative stress-related (OS-R) miRNAs is associated with muscle injury and circulating metabolic parameters in Duchenne muscular dystrophy (DMD) patients.Methods
Twenty-four DMD patients were included in this cross-sectional study. Clinical scales to evaluate muscle injury (Vignos, GMFCS, Brooke, and Medical Research Council), enzymatic muscle injury parameters (CPK, ALT, and AST), anthropometry, metabolic indicators, physical activity, serum dystromiRs (miR-1-3p, miR-133a-3p, and miR-206), and OS-R miRNAs (miR-21-5p, miR-31-5p, miR-128-3p, and miR-144-3p) levels were measured in ambulatory and non-ambulatory DMD patients.Results
DystromiRs (except miR-1-3p) and miRNAs OS-R levels were lower (p-value <.05) in the non-ambulatory group than the ambulatory group. The expression of those miRNAs correlated with Vignos scale score (For instance, rho = -0.567, p-value <0.05 for miR-21-5p) and with other scales scores of muscle function and strength. CPK, AST, and ALT concentration correlated with expression of all miRNAs (For instance, rho = 0.741, p-value <.05 between miR-206 level and AST concentration). MiR-21-5p level correlated with glucose concentration (rho = -0.369, p-value = .038), and the miR-1-3p level correlated with insulin concentration (rho = 0.343, p-value = .05).Conclusions
Non-ambulatory DMD patients have lower circulating dystromiRs and OS-R miRNAs levels than ambulatory DMD patients. The progressive muscle injury is associated with a decrease in the expression of those miRNAs, evidencing DMD progress. These findings add new information about the natural history of DMD.Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/135094121
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1111/ane.13673
Article citations
Identification and analysis of differentially expressed lncRNAs and their ceRNA networks in DMD/mdx primary myoblasts.
Sci Rep, 14(1):23691, 10 Oct 2024
Cited by: 0 articles | PMID: 39390091 | PMCID: PMC11467414
The Role of MicroRNA in the Pathogenesis of Duchenne Muscular Dystrophy.
Int J Mol Sci, 25(11):6108, 01 Jun 2024
Cited by: 2 articles | PMID: 38892293 | PMCID: PMC11172814
Review Free full text in Europe PMC
Circulating Nrf2, Glutathione, and Malondialdehyde Correlate with Disease Severity in Duchenne Muscular Dystrophy.
Antioxidants (Basel), 12(4):871, 03 Apr 2023
Cited by: 1 article | PMID: 37107246 | PMCID: PMC10135301
A Predictive Model to Evaluate the HbeAg Positivity of Chronic Hepatitis B Virus Patients in Clinics: A Cross-Sectional Study.
Medicina (Kaunas), 58(9):1279, 15 Sep 2022
Cited by: 0 articles | PMID: 36143956 | PMCID: PMC9500857
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.
PLoS One, 8(11):e80263, 25 Nov 2013
Cited by: 103 articles | PMID: 24282529 | PMCID: PMC3840009
Novel free-circulating and extracellular vesicle-derived miRNAs dysregulated in Duchenne muscular dystrophy.
Epigenomics, 12(21):1899-1915, 20 Nov 2020
Cited by: 5 articles | PMID: 33215544
Circulating Nrf2, Glutathione, and Malondialdehyde Correlate with Disease Severity in Duchenne Muscular Dystrophy.
Antioxidants (Basel), 12(4):871, 03 Apr 2023
Cited by: 1 article | PMID: 37107246 | PMCID: PMC10135301
Biomarker Potential of Extracellular miRNAs in Duchenne Muscular Dystrophy.
Trends Mol Med, 23(11):989-1001, 05 Oct 2017
Cited by: 34 articles | PMID: 28988850
Review
Funding
Funders who supported this work.
Fondo de Investigación en Salud del Instituto Mexicano del Seguro Social (1)
Grant ID: #FIS/IMSS/PROT/PRIO/19/117